Publications by authors named "Oanh Thi Mai Tran"
Article Synopsis
- - The study assesses the cost-effectiveness of one-year adjuvant trastuzumab therapy for early-stage HER2+ breast cancer patients in Vietnam, where its reimbursement rate is 60%.
- - A Markov model was created to compare the lifetime costs and effectiveness of trastuzumab combined with chemotherapy against chemotherapy alone, revealing that the additional cost of trastuzumab therapy leads to a high incremental cost-effectiveness ratio (ICER) that exceeds accepted thresholds.
- - The findings suggest that trastuzumab therapy is not cost-effective in Vietnam, but significant price reductions of the drug could make it affordable, potentially aligning it with the cost-effectiveness threshold of three times GDP per capita.
